Loading clinical trials...
Loading clinical trials...
The study assesses the accuracy of cell-free DNA (cfDNA) analysis in detecting whole chromosomal aneuploidies from maternal plasma of patients with early, missed miscarriage.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Quest Diagnostics-Nichols Insitute
Collaborators
NCT05880381 · Early Pregnancy Loss
NCT07646275 · Early Pregnancy Loss, Abortion, Spontaneous, and more
NCT06121063 · Early Pregnancy Loss, Delayed Pregnancy Loss
NCT07048587 · Pregnancy, Ectopic, Early Pregnancy Loss
NCT06036576 · Recurrent Early Pregnancy Loss, Thyroid Diseases
Quest Diagnostics
San Juan Capistrano, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions